Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BELDEN INC. Director's Dealing 2014

May 6, 2014

31053_dirs_2014-05-06_93dc9609-2b3e-4b7b-bd35-9284b88fe10c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BELDEN INC. (BDC)
CIK: 0000913142
Period of Report: 2014-05-02

Reporting Person: Norman John S (VP, Finance - M&A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-05-02 Common Stock M 6300 $40.96 Acquired 26561 Direct
2014-05-02 Common Stock D 4460 $72.92 Disposed 22101 Direct
2014-05-02 Common Stock M 5000 $11.92 Acquired 27101 Direct
2014-05-02 Common Stock D 2552 $72.92 Disposed 24549 Direct
2014-05-05 Common Stock S 4288 $72.13 Disposed 20261 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-05-02 Stock Appreciation Rights $40.96 M 6300 Disposed 2018-02-20 Common Stock (6300) Direct
2014-05-02 Stock Appreciation Rights $11.92 M 5000 Disposed 2019-02-24 Common Stock (5000) Direct

Footnotes

F1: This represents the difference between the number of SARs exercised (6,300) and the number of shares issued as a result of the exercise (1,840). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($72.92) and the exercise price ($40.96). Additional shares are then withheld to satisfy the Company's tax withholding obligations.

F2: This represents the difference between the number of SARs exercised (5,000) and the number of shares issued as a result of the exercise (2,448). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($72.92) and the exercise price ($11.92). Additional shares are then withheld to satisfy the Company's tax withholding obligations.

F3: 2,100 SARs became exercisable on February 20, 2009, 2,100 SARs became exercisable on February 20, 2010 and 2,100 SARs became exercisable on February 20, 2011.